HAVN Life Sciences Inc.
HAVLF · OTC
4/30/2022 | 4/30/2021 | 4/30/2020 | |
|---|---|---|---|
| Operating Activities | – | – | – |
| Net Income | -$22,444 | -$30,381 | -$41 |
| Dep. & Amort. | $576 | $4,605 | $0 |
| Deferred Tax | $12,573 | $0 | $0 |
| Stock-Based Comp. | $1,787 | $9,139 | $0 |
| Change in WC | -$536 | -$615 | -$34 |
| Other Non-Cash | $169 | $6,830 | -$1 |
| Operating Cash Flow | -$7,875 | -$10,422 | -$75 |
| Investing Activities | – | – | – |
| PP&E Inv. | -$103 | -$33 | $0 |
| Net Acquisitions | -$1,200 | -$346 | $0 |
| Inv. Purchases | $0 | $0 | $0 |
| Inv. Sales/Matur. | $0 | $0 | $0 |
| Other Inv. Act. | -$728 | -$18 | -$250 |
| Investing Cash Flow | -$2,031 | -$397 | -$250 |
| Financing Activities | – | – | – |
| Debt Repay. | -$131 | -$33 | $0 |
| Stock Issued | $2,000 | $14,133 | $1,922 |
| Stock Repurch. | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 |
| Other Fin. Act. | -$309 | $4,503 | $20 |
| Financing Cash Flow | $1,560 | $18,603 | $1,942 |
| Forex Effect | $0 | $0 | $0 |
| Net Chg. in Cash | -$8,346 | $7,785 | $1,617 |
| Supplemental Information | – | – | – |
| Beg. Cash | $9,402 | $1,617 | -$0 |
| End Cash | $1,056 | $9,402 | $1,617 |
| Free Cash Flow | -$7,978 | -$10,455 | -$75 |